Summary
77 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 32 USD is left as net profit.
- It holds more cash than debt: $120.6M against $16.9M.
- It has raised its dividend 8 years in a row and pays out only 46% of profit.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue grew by only 1.8% a year over the last 3 years.
- Analysts expect revenue to fall by 3.1% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.3 USD for 1 USD of yearly profit. Over the last five years it was 33.2 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.7% a year over 5 years. Over the last 3 years it grew by 1.8% a year. For the next fiscal year analysts expect revenue to fall by 3.1%. Earnings per share grew by 4.9% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 25 USD
- Research and development 24 USD
- Sales and administration 17 USD
- Taxes and other 1.8 USD
- Net profit 32 USD
Net profit, industry median (Hardware, Equipment & Parts) 6.7 USD
Out of every 100 USD of revenue, 32 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 2.50%
- Paid out of profit
- 46%
- Raised in a row
- 8 years
You receive $1.95 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 12
- Hold 6
- Sell 1
Today's price within the analysts' price targets
The average target of $122.6 is 57% above today's price. 63% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Material Sales 54%
- Royalty And License Fees 42%
- Contract Research Services 3.5%
By region
- Non-US 49%
- KOREA, REPUBLIC OF 30%
- CHINA 19%
- UNITED STATES 1.9%
- JAPAN 0.2%
- Other 0.1%
Material Sales brings in 54% of revenue. Contract Research Services grew fastest, by 9.1% a year.
Segments in detail